크레센트 바이오파머
CBIO · 최근 15건
8
매수
7
매도
+$78.8M
순매수
거래 내역
Harwin Peter Evan
Director · 2026. 7. 16.
+$7.6M
매수
Fairmount Funds Management LLC
Director · 2026. 7. 16.
+$12.4M
매수
Fairmount Funds Management LLC
Director · 2026. 7. 16.
+$7.6M
매수
Fairmount Healthcare Fund II L.P.
Director · 2026. 7. 16.
+$12.4M
매수
Fairmount Healthcare Fund II L.P.
Director · 2026. 7. 16.
+$7.6M
매수
Kiselak Tomas
Director · 2026. 7. 16.
+$12.4M
매수
Kiselak Tomas
Director · 2026. 7. 16.
+$7.6M
매수
Harwin Peter Evan
Director · 2026. 7. 16.
+$12.4M
매수
Pinkas Jan
Chief Scientific Officer · 2026. 6. 22.
−$23K
매도
Scalzo Richard William
Chief Financial Officer · 2026. 6. 22.
−$20K
매도
Bispham Barbara Harlin
See Remarks · 2026. 6. 22.
−$22K
매도
Im Ellie Eunkyung
Chief Medical Officer · 2026. 6. 22.
−$22K
매도
McNeill Jonathan
President and COO · 2026. 6. 22.
−$370K
매도
Brumm Joshua T
Chief Executive Officer · 2026. 6. 22.
−$761K
매도
Lynch Ryan
See Remarks · 2026. 6. 22.
−$8K
매도